vs
Side-by-side financial comparison of Beam Global (BEEM) and Protalix BioTherapeutics, Inc. (PLX). Click either name above to swap in a different company.
Protalix BioTherapeutics, Inc. is the larger business by last-quarter revenue ($9.1M vs $9.0M, roughly 1.0× Beam Global). Beam Global runs the higher net margin — -25.8% vs -60.3%, a 34.6% gap on every dollar of revenue. On growth, Beam Global posted the faster year-over-year revenue change (6.7% vs -49.9%). Protalix BioTherapeutics, Inc. produced more free cash flow last quarter ($1.6M vs $-3.8M). Over the past eight quarters, Protalix BioTherapeutics, Inc.'s revenue compounded faster (-6.7% CAGR vs -21.2%).
Suntory Global Spirits Inc., formerly known as Beam Suntory, Inc., and before that as Beam, Inc., is an American beverage company that is a subsidiary of Suntory Holdings, a Japanese multinational beverage conglomerate. The company produces alcoholic beverages.
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
BEEM vs PLX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.0M | $9.1M |
| Net Profit | $-2.3M | $-5.5M |
| Gross Margin | 17.8% | 49.4% |
| Operating Margin | -29.3% | -51.1% |
| Net Margin | -25.8% | -60.3% |
| Revenue YoY | 6.7% | -49.9% |
| Net Profit YoY | 49.6% | -184.8% |
| EPS (diluted) | — | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.0M | $9.1M | ||
| Q3 25 | $5.8M | $17.9M | ||
| Q2 25 | $7.1M | $15.7M | ||
| Q1 25 | $6.3M | $10.1M | ||
| Q4 24 | $8.5M | $18.2M | ||
| Q3 24 | $11.5M | $18.0M | ||
| Q2 24 | $14.8M | $13.5M | ||
| Q1 24 | $14.6M | — |
| Q4 25 | $-2.3M | $-5.5M | ||
| Q3 25 | $-4.9M | $2.4M | ||
| Q2 25 | $-4.3M | $164.0K | ||
| Q1 25 | $-15.5M | $-3.6M | ||
| Q4 24 | $-4.6M | $6.5M | ||
| Q3 24 | $1.3M | $3.2M | ||
| Q2 24 | $-4.9M | $-2.2M | ||
| Q1 24 | $-3.0M | — |
| Q4 25 | 17.8% | 49.4% | ||
| Q3 25 | -0.5% | 53.4% | ||
| Q2 25 | 20.3% | 62.5% | ||
| Q1 25 | 7.9% | 19.1% | ||
| Q4 24 | 26.3% | 78.7% | ||
| Q3 24 | 10.7% | 53.4% | ||
| Q2 24 | 15.9% | 29.8% | ||
| Q1 24 | 10.2% | — |
| Q4 25 | -29.3% | -51.1% | ||
| Q3 25 | -84.2% | 11.9% | ||
| Q2 25 | -63.1% | 7.5% | ||
| Q1 25 | -245.8% | -41.0% | ||
| Q4 24 | -60.1% | 39.6% | ||
| Q3 24 | 11.2% | 22.2% | ||
| Q2 24 | -32.3% | -18.0% | ||
| Q1 24 | -20.9% | — |
| Q4 25 | -25.8% | -60.3% | ||
| Q3 25 | -84.1% | 13.2% | ||
| Q2 25 | -60.5% | 1.0% | ||
| Q1 25 | -245.5% | -35.8% | ||
| Q4 24 | -54.5% | 35.6% | ||
| Q3 24 | 11.3% | 18.0% | ||
| Q2 24 | -33.2% | -16.4% | ||
| Q1 24 | -20.9% | — |
| Q4 25 | — | $-0.06 | ||
| Q3 25 | $-0.28 | $0.03 | ||
| Q2 25 | $-0.28 | $0.00 | ||
| Q1 25 | $-1.04 | $-0.05 | ||
| Q4 24 | $-0.31 | $0.10 | ||
| Q3 24 | $0.09 | $0.03 | ||
| Q2 24 | $-0.34 | $-0.03 | ||
| Q1 24 | $-0.21 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $969.0K | $14.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $24.8M | $48.2M |
| Total Assets | $42.7M | $82.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $969.0K | $14.7M | ||
| Q3 25 | $3.3M | $13.6M | ||
| Q2 25 | — | $17.9M | ||
| Q1 25 | — | $19.5M | ||
| Q4 24 | $4.6M | $19.8M | ||
| Q3 24 | — | $27.4M | ||
| Q2 24 | — | $23.4M | ||
| Q1 24 | — | — |
| Q4 25 | $24.8M | $48.2M | ||
| Q3 25 | $26.5M | $52.9M | ||
| Q2 25 | $26.9M | $49.9M | ||
| Q1 25 | $26.7M | $45.2M | ||
| Q4 24 | $41.3M | $43.2M | ||
| Q3 24 | $46.4M | $32.4M | ||
| Q2 24 | $43.4M | $28.6M | ||
| Q1 24 | $46.9M | — |
| Q4 25 | $42.7M | $82.3M | ||
| Q3 25 | $44.6M | $82.3M | ||
| Q2 25 | $46.7M | $78.5M | ||
| Q1 25 | $46.8M | $73.9M | ||
| Q4 24 | $61.5M | $73.4M | ||
| Q3 24 | $67.3M | $61.6M | ||
| Q2 24 | $71.9M | $91.5M | ||
| Q1 24 | $75.7M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.8M | $2.0M |
| Free Cash FlowOCF − Capex | $-3.8M | $1.6M |
| FCF MarginFCF / Revenue | -42.3% | 17.8% |
| Capex IntensityCapex / Revenue | 0.6% | 4.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-11.8M | $-13.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.8M | $2.0M | ||
| Q3 25 | $-4.6M | $-3.7M | ||
| Q2 25 | $-318.0K | $-5.2M | ||
| Q1 25 | $-1.8M | $-5.1M | ||
| Q4 24 | $859.0K | $4.0M | ||
| Q3 24 | $-3.0M | $4.1M | ||
| Q2 24 | $2.9M | $-3.6M | ||
| Q1 24 | $-3.0M | — |
| Q4 25 | $-3.8M | $1.6M | ||
| Q3 25 | $-5.1M | $-4.2M | ||
| Q2 25 | $-1.1M | $-5.7M | ||
| Q1 25 | $-1.8M | $-5.4M | ||
| Q4 24 | $462.0K | $3.6M | ||
| Q3 24 | $-3.1M | $4.0M | ||
| Q2 24 | $2.8M | $-3.8M | ||
| Q1 24 | $-3.1M | — |
| Q4 25 | -42.3% | 17.8% | ||
| Q3 25 | -87.9% | -23.7% | ||
| Q2 25 | -15.2% | -36.2% | ||
| Q1 25 | -28.7% | -53.0% | ||
| Q4 24 | 5.4% | 19.6% | ||
| Q3 24 | -27.4% | 22.4% | ||
| Q2 24 | 18.9% | -28.1% | ||
| Q1 24 | -21.5% | — |
| Q4 25 | 0.6% | 4.4% | ||
| Q3 25 | 7.8% | 2.8% | ||
| Q2 25 | 10.7% | 2.8% | ||
| Q1 25 | 0.9% | 3.0% | ||
| Q4 24 | 4.7% | 2.3% | ||
| Q3 24 | 1.7% | 0.5% | ||
| Q2 24 | 0.9% | 1.3% | ||
| Q1 24 | 0.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | -2.28× | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BEEM
| Products | $7.0M | 77% |
| Other | $2.0M | 23% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
